JANX in the 13F filings
Janux Therapeutics Inc · CUSIP 47103J105
- Quarter end
- 30 Sep 2025
- the date the book describes
- Filed
- 17 Feb 2026
- latest of these filings; the earliest 14 Nov 2025
- Managers listing it
- 3
- at least, of 95 tracked, among listed positions
- Comparable managers
- 95
- filed both Q2 2025 and Q3 2025; 3 listed it in both
- Shares listed
- 7,438,250
- combined, among listed positions
- Reported value
- $182m
- combined, at the quarter end
Among the 95 comparable managers: 1 buyer (opened or added shares) and 3 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was -455,920.
Managers listing JANX in Q3 2025
3 of 3 holders
| Action | Filing | |||||
|---|---|---|---|---|---|---|
| Janus Henderson Group Ltd | 4,701,112 | $115m | 0.05% | Added | +240,780 | 14 Nov 2025 (the filing on sec.gov) |
| Point72 Asset Management LP | 1,710,200 | $42m | 0.07% | Trimmed | -433,700 | 14 Nov 2025 (the filing on sec.gov) |
| Woodline Partners LP | 1,026,938 | $25m | 0.12% | Trimmed | -215,000 | 14 Nov 2025 (the filing on sec.gov) |
Largest increases and reductions, by shares
Increases
- Janus Henderson Group Ltdexisting position · 4,701,112 shares now+240,780
Reductions
- Point72 Asset Management LPexisting position · 1,710,200 shares now-433,700
- Woodline Partners LPexisting position · 1,026,938 shares now-215,000
New positions and exits
New (0)
No new position among listed positions.
Exited (1)
- Farallon Capital Management LLCwas $1.1m
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2021 | 1 | $8.3m | n.a. | n.a. |
| Q3 2021 | 1 | $6.5m | n.a. | n.a. |
| Q4 2021 | 1 | $5.5m | n.a. | n.a. |
| Q1 2022 | 1 | $4.0m | n.a. | n.a. |
| Q2 2022 | 1 | $3.5m | n.a. | n.a. |
| Q3 2022 | 1 | $5.4m | n.a. | n.a. |
| Q4 2022 | 1 | $6.7m | n.a. | n.a. |
| Q1 2023 | 1 | $1.7m | n.a. | n.a. |
| Q2 2023 | 1 | $1.6m | n.a. | n.a. |
| Q3 2023 | 1 | $864k | n.a. | n.a. |
| Q1 2024 | 3 | $76m | 3 | 0 |
| Q2 2024 | 3 | $98m | 2 | 2 |
| Q3 2024 | 5 | $218m | 4 | 1 |
| Q4 2024 | 8 | $850m | 6 | 1 |
| Q1 2025 | 3 | $174m | 1 | 2 |
| Q2 2025 | 4 | $182m | 1 | 2 |
| Q3 2025 | 3 | $182m | 1 | 3 |
| Q4 2025 | 2 | $88m | 21 | 6 |
| Q1 2026 | 1 | $58m | 10 | 14 |
| Q2 2026 | 1 | $1.4m | 14 | 13 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
JANX and LLY →JANX and JNJ →JANX and VRTX →Choose a stock to compare with JANX →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own JANX, latest filings →Back to the 13F Explorer →